Part of the Bay Area News Group

Big Pharma’s money talks in the U.S. Senate

By Josh Richman
Wednesday, December 16th, 2009 at 4:10 pm in healthcare reform, U.S. Senate.

The pharmaceutical industry’s political donations paid-off big time yesterday, according to the great data-crunchers at Berkeley-based MAPLight.org.

The U.S. Senate voted 51-48 yesterday on an health-care reform bill amendment – offered by U.S. Sen. Byron Dorgan, D-ND – which would’ve relaxed restrictions on drug imports from Canada and other developed nations, paving the way for the U.S. market’s access to cheaper prescription drugs. It failed, because under rules governing consideration of the overall reform bill the proposal required 60 votes.

The parties may differ on health-care reform, but this amendment’s defeat was startlingly bipartisan: 30 Democrats joined 17 Republicans and one independent to kill it.

The pharmaceutical industry opposed this amendment, claiming risks of counterfeit medicines and sub-standard regulations; Dorgan argued in the amendment’s text that “a prescription drug is neither safe nor effective to an individual who cannot afford it.” The amendment’s backers estimated it would save American consumers $100 billion over 10 years.

And, don’t’cha know, Senate Democrats who voted against this amendment had received an average of $73,729 from drug companies over the past six years – 70 percent more than Democrats who voted for the amendment, MAPLight.org found. Among all Senators, those voting to block imports received an average of $85,812 each from drug companies over the past six years, which is 66 percent more than those who voted in favor of imports.

U.S. Sen. Barbara Boxer, D-Calif., was among the amendment’s 20 cosponsors; both she and U.S. Sen. Dianne Feinstein, D-Calif., voted in favor of it.

MAPLight.org’s averages for yesterday’s vote exclude U.S. Sen. Robert Byrd, D-W.Va., who didn’t vote, and recently elected or appointed senators Roland Burris, D-Ill.; Paul Kirk, D-Mass.; Herbert Kohl, D-Wisc.; and George LeMieux, R-Fla., for whom campaign finance records are not yet available.

[You can leave a response, or trackback from your own site.]

  • RR, Uninvited Columnist

    Big Pharma strikes again! Besides the meds makers, there’s Big Oil, Big Banks, Big Telecom and Big HMOs.
    At least Big Steel, Big Auto and Big Coal aren’t as much of a menace as they used to be. The Mining Kings, the Factory Kings and the Robber Barons have had their day. I wonder if Tom Paine warned us about Big Money poisoning the atmosphere in Philadelphia?

  • Josh Richman

    In fact, RR, you probably know that many of the founding fathers favored establishing our nation’s capital in a new, federal city – Washington, D.C. – in order to be distanced from the moneyed interests in New York and Philadelphia which already were influencing the fledgling nation’s politics.

  • JK

    Or should we say: Big Paranoia.

    Blog postings that try to tie votes to “Big Pharma” based on $70k over 6 years really belong in the 1970 era of delusion.

    Big Edu, Big Gov, Big Media, and Big Unions are the real talkers in the Senate these days, to be honest. These dictatorial powers push there agenda of less individual freedom and lower prosperity with reckless abandon.

  • Ralph Hoffmann, Guest Columnist

    You probably know also, RR and Josh, that Big Pharma is the largest of all of the lobbies. Pharma companies bribe docs with samples, gifts, and trips. The TV Industry would have hard times if drug ads were banned from TV, as they are in many developed countries. Should you ask your Physician, “Please prescribe this drug for me because I saw an ad on TV for it.”?

  • Tom Benigno

    Good morning Ralph, what’s new in the 11th this morning.

  • John W.

    While I agree with the sentiments expressed here, I think the way people voted yesterday was about more than Senators being bought and paid for. Like it or not, part of the health reform deal the Obama people negotiated with Pharma was to cut Medicare drug prices in order the close the hated and growing “donut hole” in the Medicare prescription drug program. If yesterday’s proposal would have passed, that part of the health reform bill would have been in jeopardy.

  • Elwood

    “Big Pharma’s money talks in the U.S. Senate”

    And this surprises who, how?

  • Ralph Hoffmann, Guest Columnist

    Merry Christmas, Tom. BTW, I’m in the 10th CD, the 7th SD, and the 15th AD, here in WC. Let’s hope for a Happy New Year!